Association between serum interleukin 10 level and development of heart failure in acute myocardial infarction patients treated by primary angioplasty;Asociación entre concentraciones séricas de interleucina 10 y desarrollo de insuficiencia cardíaca en pacientes con infarto agudo de miocardio tratados con angioplastia primaria

Revista Espanola de Cardiologia

Volumn 58, Issue 6, 2005, Pages 626-630

  Domínguez Rodríguez, Alberto ^a,c   Abreu González, Pedro ^b   García González, Martin J ^a   Ferrer Hita, Julio ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c NONE   (Spain)

Author keywords

Coronary angioplasty; Heart failure; Inflammation; Interleukin; Myocardial infarction

Indexed keywords

INTERLEUKIN 10;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CORONARY CARE UNIT; CORONARY RISK; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 23044481471     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076414     Document Type: Article

References (24)

1. García-Moll X, Kaski JC. Cardiopatía isquémica: marcadores de inflamación y riesgo cardiovascular. Rev Esp Cardiol. 1999;52: 990-1003.
2. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-8.
3. Katz AM. Heart failure. The hemodynamic defense reaction. Pathophysiology, molecular biology and clinical management. Philadelphia: Lippincott, Williams & Wilking, 2000; p. 109-52.
4. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol. 1997;80:L15-25.
5. Roig Minguell E. Utilidad clínica de los marcadores neurohormonales en la insuficiencia. cardíaca. Rev Esp Cardiol. 2004;57:347-56.
6. Pérez Fernández R, Kaski JC. Interleucina-10 y enfermedad coronaria. Rev Esp Cardiol. 2002;55:738-50.
7. Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res. 1997;17:145-50.
8. Seghaye M, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996;111:545-53.
9. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Mori A. Interleukin-10 concentration in children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:1127-8.
10. Wan S, Marchant A, Desmet JM, Antoine M, Zhang H, Vachiery JL, et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996;111:469-77.
11. Domínguez A, Abreu P, Vargas M, De la Rosa A, Ferrer J, García MJ. Interleukin-10 and lipid peroxidation after primary angioplasty [abstract]. J Coron Art Dis. 2003;5:13.
12. Domínguez-Rodríguez A, Abreu-González P, De la Rosa A, Vargas M, Ferrer J, García M. Role of endogenous interleukin-10 production and lipid peroxidation in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty. Int J Cardiol. 2005;99:77-81.
13. TIMI Study Group. The Trombolysis in Myocardial Infarction (TIMI) trial: phase I Findings. N Engl J Med. 1985;312:932-6.
14. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-64.
15. Rohlfs I, Elosua R, Masia R, Sala J, Marrugat J, en representación de los investigadores del REGICOR. Tendencias en la proporción de pacientes menores de 75 años con infarto agudo de miocardio que presentan Killip III-IV. Variables asociadas con su aparición y con el pronóstico: 1978-1997. Rev Esp Cardiol. 2002;55:1117-23.
16. Nishii M, Inomata T, Takehana H, Takeuchi I, Nakano H, Koitabashi T, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004;44:1292-7.
17. Knowlton KU, Yajima T. Interleukin-10: biomarker of pathologic cytokine in fulminant myocarditis? J Am Coll Cardiol. 2004; 44: 1298-300.
18. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 1999;19:611-6.
19. Smith D, Irving S, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001;104:746-9.
20. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995;92:748-55.
21. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998-3002.
22. Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischaemia/reperfusion injury. Circulation. 2000;101:1019-26.
23. Liuzzo G, Biasucci LM, Callimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994;331:417-24.
24. Sarjuán-Máñez R, Blasco-Cortés M, Muñoz-Gil J, Gimeno-Cardona C, Savall Calvo F, Ferreres Franco J, et al. Respuesta inflamatoria en el infarto agudo de miocardio. Valores predictivos. Rev Esp Cardiol. 1997;50:561-6.